Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05151367 · ClinicalTrials.gov registry record · NA
SMS HPV Vaccine Reminders
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 154
- Enrollment target
NCT05151367 is a NA study that has completed, run by Columbia University. The registered enrollment target is 154 participants.
The verdict
NCT05151367, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 154 participants
- Enrollment target
Study Summary
This study will take place at health centres and their affiliated schools and community immunization centers overseen by the Kampala Capital City Authority (KCCA) as well as at the Makerere/Mulago/Columbia Adolescent Health Clinic, also in Kampala. While text messages can be used in populations with low literacy, families can opt to receive automated phone call reminders instead. The investigators will pilot assess the impact of vaccine reminders on human papillomavirus (HPV) vaccination. Caregivers of preteens/adolescents will be randomized and stratified by site, language and HPV vaccine dose needed (initiation vs. completion). As this is a feasibility trial, the investigators expect to measure effect size but not necessarily achieve statistical significance.
Interventions
- BEHAVIORAL Text message reminder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2022-02-23 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05151367
The ClinicalTrials.gov registry entry for NCT05151367 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Text message reminder is the first listed.
NCT05151367 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05151367 about?
NCT05151367 is a clinical study titled "SMS HPV Vaccine Reminders". This study will take place at health centres and their affiliated schools and community immunization centers overseen by the Kampala Capital City Authority (KCCA) as well as at the Makerere/Mulago/Columbia Adolescent Health Clinic, also in Kampala. While text messages can be used in populations with...
What is the current status of trial NCT05151367?
This trial is currently completed. It is a NA study. The enrollment target is 154 participants. The study started on 2022-02-23. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT05151367?
The interventions under investigation include: Text message reminder (BEHAVIORAL).
Who is sponsoring clinical trial NCT05151367?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.